{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:36Z","timestamp":1792788036587,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Japanese Ministry of Health, Labour and Welfare","id":[{"id":"https:\/\/ror.org\/03mwa7s65","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Japan Agency for Medical Research and Development","award":["25ek0109794h0001"],"award-info":[{"award-number":["25ek0109794h0001"]}],"id":[{"id":"https:\/\/ror.org\/004rtk039","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcoidosis is a systemic granulomatous disease, often affecting the lungs, with a generally favourable prognosis. However, some patients experience progressive disease, and cardiac involvement may worsen outcomes. Data on the clinical course and causes of death in pulmonary sarcoidosis (PS), particularly with coexisting cardiac sarcoidosis (CS), remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analysed patients with histologically confirmed PS. Baseline evaluations included chest X-ray and computed tomography, pulmonary function tests, and echocardiography. CS was diagnosed based on the findings of\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance imaging in patients who met the predefined clinical screening criteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 513 patients met the study criteria. The 3-, 5-, and 10-year survival rates were 98.2%, 97.0%, and 94.6%, respectively (median follow-up: 6.7 years). CS was diagnosed in 48 patients (9.4%), and survival was poorer in those with CS (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004 by log rank test). Multivariate analysis showed that CS was associated with increased all-cause mortality after adjustment for age or sex (age-adjusted hazard ratio 3.55, 95% CI 1.18\u201310.6; sex-adjusted hazard ratio 3.79, 95% CI 1.28\u201311.2). During follow-up, 21 patients (4.6%) died. Malignancy was the leading cause of death (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910, 48%), followed by cardiac death (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093, 14%) and respiratory failure (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093, 14%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this Japanese single-centre cohort of patients with predominantly mild histologically confirmed PS, CS identified through a screening-based diagnostic pathway was associated with increased all-cause mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-026-04458-x","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:34:09Z","timestamp":1782747249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and cardiac magnetic resonance-proven cardiac involvement in pulmonary sarcoidosis: a single centre long-term cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuhei","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Oyama-Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satonori","family":"Tsuneta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichizo","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"8","key":"4458_CR1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u201351.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"4458_CR2","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis\u3000- digest version. Circ J. 2019;83(11):2329\u201388.","journal-title":"Circ J"},{"issue":"2","key":"4458_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1183\/09031936.00075307","volume":"31","author":"T Morimoto","year":"2008","unstructured":"Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31(2):372\u20139.","journal-title":"Eur Respir J"},{"key":"4458_CR4","doi-asserted-by":"publisher","first-page":"106762","DOI":"10.1016\/j.rmed.2022.106762","volume":"195","author":"MP Huitema","year":"2022","unstructured":"Huitema MP, Mathijssen H, Bakker ALM, Mager JJ, van Houten L, Grutters JC, Post MC. Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening. Respir Med. 2022;195:106762.","journal-title":"Respir Med"},{"issue":"1","key":"4458_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","volume":"153","author":"G Kirkil","year":"2018","unstructured":"Kirkil G, Lower EE, Baughman RP. Predictors of mortality in pulmonary sarcoidosis. Chest. 2018;153(1):105\u201313.","journal-title":"Chest"},{"issue":"2","key":"4458_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","volume":"2","author":"SL Walsh","year":"2014","unstructured":"Walsh SL, Wells AU, Sverzellati N, Keir GJ, Calandriello L, Antoniou KM, et al. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir Med. 2014;2(2):123\u201330.","journal-title":"Lancet Respir Med"},{"issue":"48","key":"4458_CR7","doi-asserted-by":"publisher","first-page":"e23100","DOI":"10.1097\/MD.0000000000023100","volume":"99","author":"MC Lopes","year":"2020","unstructured":"Lopes MC, Amadeu TP, Ribeiro-Alves M, Costa CHD, Silva BRA, Rodrigues LS, et al. Defining prognosis in sarcoidosis. Med (Baltim). 2020;99(48):e23100.","journal-title":"Med (Baltim)"},{"issue":"6","key":"4458_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204\u201311.","journal-title":"Circulation"},{"issue":"9","key":"4458_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","volume":"88","author":"Y Yazaki","year":"2001","unstructured":"Yazaki Y, Isobe M, Hiroe M, Morimoto S, Hiramitsu S, Nakano T, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006\u201310.","journal-title":"Am J Cardiol"},{"issue":"3","key":"4458_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1055\/s-0034-1376889","volume":"35","author":"JP Lynch 3rd","year":"2014","unstructured":"Lynch JP 3rd, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35(3):372\u201390.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"4458_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0735-1097(02)02715-8","volume":"41","author":"Y Okura","year":"2003","unstructured":"Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41(2):322\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"7\u20138","key":"4458_CR12","first-page":"372","volume":"43","author":"K Iwai","year":"1993","unstructured":"Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43(7\u20138):372\u20136.","journal-title":"Acta Pathol Jpn"},{"issue":"11","key":"4458_CR13","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","volume":"183","author":"JJ Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183(11):1524\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4458_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","volume":"63","author":"WC Roberts","year":"1977","unstructured":"Roberts WC, McAllister HA Jr., Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63(1):86\u2013108.","journal-title":"Am J Med"},{"key":"4458_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1749-6632.1986.tb18531.x","volume":"465","author":"HA Fleming","year":"1986","unstructured":"Fleming HA, Bailey SM. The prognosis of sarcoid heart disease in the United Kingdom. Ann N Y Acad Sci. 1986;465:543\u201350.","journal-title":"Ann N Y Acad Sci"},{"issue":"36","key":"4458_CR16","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","volume":"43","author":"T Nabeta","year":"2022","unstructured":"Nabeta T, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, et al. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry. Eur Heart J. 2022;43(36):3450\u20139.","journal-title":"Eur Heart J"},{"issue":"12","key":"4458_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","volume":"10","author":"V Kouranos","year":"2017","unstructured":"Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, et al. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2017;10(12):1437\u201347.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"37","key":"4458_CR18","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","volume":"40","author":"K Ekstr\u00f6m","year":"2019","unstructured":"Ekstr\u00f6m K, Lehtonen J, Nordenswan HK, M\u00e4yr\u00e4np\u00e4\u00e4 MI, R\u00e4is\u00e4nen-Sokolowski A, Kandolin R, et al. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J. 2019;40(37):3121\u20138.","journal-title":"Eur Heart J"},{"key":"4458_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","volume":"278","author":"Y Matsui","year":"1976","unstructured":"Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455\u201369.","journal-title":"Ann N Y Acad Sci"},{"issue":"15","key":"4458_CR20","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","volume":"26","author":"S Ishimaru","year":"2005","unstructured":"Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26(15):1538\u201343.","journal-title":"Eur Heart J"},{"issue":"5","key":"4458_CR21","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","volume":"35","author":"H Ohira","year":"2008","unstructured":"Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2008;35(5):933\u201341.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"4458_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1378\/chest.128.1.30","volume":"128","author":"JP Smedema","year":"2005","unstructured":"Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest. 2005;128(1):30\u20135.","journal-title":"Chest"},{"issue":"2","key":"4458_CR23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1378\/chest.14-1120","volume":"147","author":"M Mirsaeidi","year":"2015","unstructured":"Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147(2):438\u201349.","journal-title":"Chest"},{"issue":"1","key":"4458_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","volume":"157","author":"JS Kim","year":"2009","unstructured":"Kim JS, Judson MA, Donnino R, Gold M, Cooper LT Jr., Prystowsky EN, Prystowsky S. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9\u201321.","journal-title":"Am Heart J"},{"key":"4458_CR25","first-page":"59","volume":"44","author":"S Konno","year":"2023","unstructured":"Konno S, Shijubo N, Suda T. Diagnostic standard 2023 and classification of disease severity for sarcoidosis in Japan. Jpn J Sarcoidosis Other Granulomatous Disord. 2023;44:59\u201363.","journal-title":"Jpn J Sarcoidosis Other Granulomatous Disord"},{"issue":"9","key":"4458_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","volume":"327","author":"JA Belperio","year":"2022","unstructured":"Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, Lynch JP. 3rd. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327(9):856\u201367.","journal-title":"JAMA"},{"issue":"7","key":"4458_CR27","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1164\/rccm.2111053","volume":"167","author":"AU Wells","year":"2003","unstructured":"Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med. 2003;167(7):962\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"4458_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","volume":"83","author":"K Fukuda","year":"2019","unstructured":"Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, et al. Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS 2017). Circ J. 2019;83(4):842\u2013945.","journal-title":"Circ J"},{"issue":"4","key":"4458_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u201375.","journal-title":"Eur Respir J"},{"issue":"8","key":"4458_CR30","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2967\/jnumed.116.187203","volume":"58","author":"H Ohira","year":"2017","unstructured":"Ohira H, Ardle BM, deKemp RA, Nery P, Juneau D, Renaud JM, et al. Inter- and Intraobserver agreement of (18)F-FDG PET\/CT image interpretation in patients referred for assessment of cardiac sarcoidosis. J Nucl Med. 2017;58(8):1324\u20139.","journal-title":"J Nucl Med"},{"issue":"2","key":"4458_CR31","first-page":"188","volume":"36","author":"ML Bartlett","year":"1995","unstructured":"Bartlett ML, Bacharach SL, Voipio-Pulkki LM, Dilsizian V. Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. J Nucl Med. 1995;36(2):188\u201395.","journal-title":"J Nucl Med"},{"issue":"8","key":"4458_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI-ASNC Expert Consensus Document on the Role of (18)F-FDG PET\/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017;58(8):1341\u201353.","journal-title":"J Nucl Med"},{"issue":"9","key":"4458_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.amjmed.2019.03.048","volume":"132","author":"F Ogundipe","year":"2019","unstructured":"Ogundipe F, Mehari A, Gillum R. Disparities in sarcoidosis mortality by region, urbanization, and race in the United States: a multiple cause of death analysis. Am J Med. 2019;132(9):1062\u2013e83.","journal-title":"Am J Med"},{"key":"4458_CR34","doi-asserted-by":"publisher","first-page":"106828","DOI":"10.1016\/j.rmed.2022.106828","volume":"196","author":"K Harada","year":"2022","unstructured":"Harada K, Hagiya H, Koyama T, Otsuka F. Trends in sarcoidosis mortality rate in Japan from 2001 to 2020: a population-based study. Respir Med. 2022;196:106828.","journal-title":"Respir Med"},{"key":"4458_CR35","doi-asserted-by":"publisher","first-page":"s28","DOI":"10.1016\/j.rmed.2018.03.028","volume":"144s","author":"JE Park","year":"2018","unstructured":"Park JE, Kim YS, Kang MJ, Kim CJ, Han CH, Lee SM, Park SC. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003\u20132015: a nationwide population-based study. Respir Med. 2018;144s:s28\u201334.","journal-title":"Respir Med"},{"issue":"5","key":"4458_CR36","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2024.10.043","volume":"167","author":"MI Seedahmed","year":"2025","unstructured":"Seedahmed MI, Albirair MT, Baugh AD, Gellad WF, Nouraie SM, Gibson KF, et al. Trends in all-Cause mortality among US veterans with sarcoidosis, 2004\u20132022. Chest. 2025;167(5):1416\u201327.","journal-title":"Chest"},{"issue":"4","key":"4458_CR37","first-page":"e2023054","volume":"40","author":"B Bilgin","year":"2023","unstructured":"Bilgin B, Bilgin MK, Erol S, Celik G, Ozdemir Kumbasar O. Prognosis of sarcoidosis and factors affecting prognosis. Sarcoidosis Vasc Diffuse Lung Dis. 2023;40(4):e2023054.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"6","key":"4458_CR38","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1183\/09031936.00187410","volume":"38","author":"A Nardi","year":"2011","unstructured":"Nardi A, Brillet PY, Letoumelin P, Girard F, Brauner M, Uzunhan Y, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J. 2011;38(6):1368\u201373.","journal-title":"Eur Respir J"},{"issue":"5","key":"4458_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/crj.12398","volume":"11","author":"A Nowi\u0144ski","year":"2017","unstructured":"Nowi\u0144ski A, Pu\u015bci\u0144ska E, Goljan A, Peradzynska J, Bednarek M, Korzybski D, et al. The influence of comorbidities on mortality in sarcoidosis: a observational prospective cohort study. Clin Respir J. 2017;11(5):648\u201356.","journal-title":"Clin Respir J"},{"key":"4458_CR40","doi-asserted-by":"publisher","first-page":"107954","DOI":"10.1016\/j.rmed.2025.107954","volume":"238","author":"J Nakamura","year":"2025","unstructured":"Nakamura J, Sato T, Ohira H, Yoshikawa S, Hattori T, Manabe O, et al. Prevalence, incidence, and clinical features of cardiac involvement in patients with pulmonary sarcoidosis. Respir Med. 2025;238:107954.","journal-title":"Respir Med"},{"key":"4458_CR41","doi-asserted-by":"publisher","first-page":"3738354","DOI":"10.1155\/crp\/3738354","volume":"2026","author":"I Antoun","year":"2026","unstructured":"Antoun I, Assadi J, Zakkar M, Ng GA, Bhandari SS. Beyond the biopsy: imaging frontiers in cardiac sarcoidosis. Cardiol Res Pract. 2026;2026:3738354.","journal-title":"Cardiol Res Pract"},{"key":"4458_CR42","unstructured":"Ministry of Health LaWoJ. Vital Statistics of Japan 2019: Final Data (Confirmed Report) Tokyo, Japan: Ministry of Health, Labour and Welfare. 2019. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei19\/."},{"issue":"2","key":"4458_CR43","first-page":"158","volume":"17","author":"A Pietinalho","year":"2000","unstructured":"Pietinalho A, Ohmichi M, L\u00f6froos AB, Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis. 2000;17(2):158\u201366.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"6","key":"4458_CR44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","volume":"57","author":"LE Siltzbach","year":"1974","unstructured":"Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, et al. Course and prognosis of sarcoidosis around the world. Am J Med. 1974;57(6):847\u201352.","journal-title":"Am J Med"},{"issue":"3","key":"4458_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4046\/trd.2017.80.3.291","volume":"80","author":"MS Kim","year":"2017","unstructured":"Kim MS, Park CK, Shin HJ, Seo HW, Chang J, Ahn S, et al. Review of sarcoidosis in a province of South Korea from 1996 to 2014. Tuberc Respir Dis (Seoul). 2017;80(3):291\u20135.","journal-title":"Tuberc Respir Dis (Seoul)"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04458-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:09Z","timestamp":1789524129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4458"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04458-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9004576\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Hokkaido University Hospital (Approval No. 017\u20130431).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I.Y. reports speaker fees from Chugai Pharmaceutical Co., and Pfizer, outside the submitted work. All other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"412"}}